within Pharmacolibrary.Drugs.ATC.H;

model H01BA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.16666666666666666,
    adminDuration  = 600,
    adminMass      = 4e-05,
    adminCount     = 1,
    Vd             = 0.00014000000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Vasopressin (also known as argipressin or antidiuretic hormone, ADH) is a peptide hormone used primarily in the treatment of diabetes insipidus, vasodilatory shock (such as septic shock), and post-cardiac arrest vasopressor support. It increases water reabsorption in the kidneys and induces vasoconstriction in vascular smooth muscle. It is approved for clinical use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult subjects, intravenous administration.</p><h4>References</h4><ol><li><p>Sotelo, CK, et al., &amp; Zersen, KM (2022). Pharmacokinetics and anti-nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea. <i>Journal of veterinary pharmacology and therapeutics</i> 45(6) 508–515. DOI:<a href=&quot;https://doi.org/10.1111/jvp.13087&quot;>10.1111/jvp.13087</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35899472/&quot;>https://pubmed.ncbi.nlm.nih.gov/35899472</a></p></li><li><p>Moen, MD, &amp; Keating, GM (2008). Intravenous conivaptan. <i>American journal of cardiovascular drugs : drugs, devices, and other interventions</i> 8(5) 341–349. DOI:<a href=&quot;https://doi.org/10.2165/00129784-200808050-00006&quot;>10.2165/00129784-200808050-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18828645/&quot;>https://pubmed.ncbi.nlm.nih.gov/18828645</a></p></li><li><p>Dunser, MW, et al., &amp; Hasibeder, WR (2003). Management of vasodilatory shock: defining the role of arginine vasopressin. <i>Drugs</i> 63(3) 237–256. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200363030-00001&quot;>10.2165/00003495-200363030-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12534330/&quot;>https://pubmed.ncbi.nlm.nih.gov/12534330</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end H01BA01;
